Biomarker analyses and association with clinical outcomes in patients

Discussion Board › Forums › Chemotherapy & More › Biomarker analyses and association with clinical outcomes in patients

Viewing 1 post (of 1 total)
  • Author
    Posts
  • May 15, 2014 at 6:17 pm #10019
    gavin
    Moderator

    Biomarker analyses and association with clinical outcomes in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib with or without erlotinib in the phase III SEARCH trial.

    Not specifically CC related but know that some are on sorafenib so thought I’d post it anyway.

    http://abstracts.asco.org/144/AbstView_144_130930.html

  • Author
    Posts
Viewing 1 post (of 1 total)
  • The forum ‘Chemotherapy & More’ is closed to new topics and replies.